Compile Data Set for Download or QSAR
Report error Found 64 Enz. Inhib. hit(s) with Target = 'Chloride channel protein 2'
TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525281BDBM525281(US11173137, Compound FA44 | US11173137, Compound A...)
Affinity DataIC50: 2nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525299BDBM525299(US11173137, Compound AK3-238)
Affinity DataIC50: 120nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525279BDBM525279(US11173137, Compound FA26 | US11173137, Compound ...)
Affinity DataIC50: 200nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525314BDBM525314(US11173137, Compound MCFA)
Affinity DataIC50: 300nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525281BDBM525281(US11173137, Compound FA44 | US11173137, Compound A...)
Affinity DataIC50: 620nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525290BDBM525290(US11173137, Compound FA35 | US11173137, Compound A...)
Affinity DataIC50: 700nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525303BDBM525303(US11173137, Compound AK3-261)
Affinity DataIC50: 1.16E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525310BDBM525310(US11173137, Compound EEGI-055)
Affinity DataIC50: 1.20E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525290BDBM525290(US11173137, Compound FA35 | US11173137, Compound A...)
Affinity DataIC50: 1.79E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525280BDBM525280(US11173137, Compound AK3-99A)
Affinity DataIC50: 2.04E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525281BDBM525281(US11173137, Compound FA44 | US11173137, Compound A...)
Affinity DataIC50: 2.98E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525285BDBM525285(US11173137, Compound AK3-102A)
Affinity DataIC50: 3.60E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525284BDBM525284(US11173137, Compound AK3-101B)
Affinity DataIC50: 5.29E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525271BDBM525271(US11173137, Compound AK2-289B)
Affinity DataIC50: 7.16E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525313BDBM525313(US11173137, Compound EEGI-060)
Affinity DataIC50: 7.32E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525273BDBM525273(US11173137, Compound AK2-292)
Affinity DataIC50: 7.69E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525309BDBM525309(US11173137, Compound EEGI-054)
Affinity DataIC50: 7.93E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525270BDBM525270(US11173137, Compound AK2-289A)
Affinity DataIC50: 9.86E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525282BDBM525282(US11173137, Compound AK3-100A)
Affinity DataIC50: 1.26E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525278BDBM525278(US11173137, Compound AK3-98A)
Affinity DataIC50: 1.37E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525314BDBM525314(US11173137, Compound MCFA)
Affinity DataIC50: 1.39E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525311BDBM525311(US11173137, Compound EEGI-056)
Affinity DataIC50: 1.58E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525300BDBM525300(US11173137, Compound AK3-239)
Affinity DataIC50: 1.79E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525258BDBM525258(US11173137, Compound AK2-209A)
Affinity DataIC50: 2.21E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525272BDBM525272(US11173137, Compound AK2-289C)
Affinity DataIC50: 2.35E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525267BDBM525267(US11173137, Compound AK2-288A)
Affinity DataIC50: 2.47E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525274BDBM525274(US11173137, Compound AK3-89)
Affinity DataIC50: 3.34E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525265BDBM525265(US11173137, Compound AK2-270A)
Affinity DataIC50: 3.57E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525268BDBM525268(US11173137, Compound AK2-288B)
Affinity DataIC50: 3.79E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525288BDBM525288(US11173137, Compound AK3-107B)
Affinity DataIC50: 4.20E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525293BDBM525293(US11173137, Compound AK3-124)
Affinity DataIC50: 4.24E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525286BDBM525286(US11173137, Compound AK3-103B)
Affinity DataIC50: 4.88E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525306BDBM525306(US11173137, Compound AK3-298)
Affinity DataIC50: 5.50E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525301BDBM525301(US11173137, Compound AK3-250)
Affinity DataIC50: 6.78E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525279BDBM525279(US11173137, Compound FA26 | US11173137, Compound ...)
Affinity DataIC50: 6.90E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525312BDBM525312(US11173137, Compound EEGI-059)
Affinity DataIC50: 7.62E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525304BDBM525304(US11173137, Compound AK3-294)
Affinity DataIC50: 7.71E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525298BDBM525298(US11173137, Compound AK3-227)
Affinity DataIC50: 8.19E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525277BDBM525277(US11173137, Compound AK3-97C)
Affinity DataIC50: 8.63E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525269BDBM525269(US11173137, Compound AK2-288C)
Affinity DataIC50: 1.02E+5nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525289BDBM525289(US11173137, Compound AK3-108A)
Affinity DataIC50: 1.15E+5nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525254BDBM525254(US11173137, Compound AK2-200A)
Affinity DataIC50: 1.20E+5nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525255BDBM525255(US11173137, Compound AK2-200B)
Affinity DataIC50: 1.20E+5nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525257BDBM525257(US11173137, Compound AK2-200C)
Affinity DataIC50: 1.20E+5nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525260BDBM525260(US11173137, Compound AK2-209B)
Affinity DataIC50: 1.20E+5nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525261BDBM525261(US11173137, Compound AK2-214A)
Affinity DataIC50: 1.20E+5nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525262BDBM525262(US11173137, Compound AK2-214B)
Affinity DataIC50: 1.20E+5nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525294BDBM525294(US11173137, Compound AK3-219)
Affinity DataIC50: 1.20E+5nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525263BDBM525263(US11173137, Compound AK2-214C)
Affinity DataIC50: 1.20E+5nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

TargetChloride channel protein 2(Human)
The Leland Stanford Junior University

US Patent
LigandChemical structure of BindingDB Monomer ID 525295BDBM525295(US11173137, Compound AK3-224)
Affinity DataIC50: 1.20E+5nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
US Patent

Displayed 1 to 50 (of 64 total ) | Next | Last >>
Jump to: